Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
13.89
+0.45 (3.35%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Intellia Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,641 | 1,041 | 1,188 | 2,731 | 2,974 | 8,799 | |
| Market Cap Growth | 31.52% | -12.31% | -56.51% | -8.18% | -66.20% | 150.41% | |
| Enterprise Value | 1,129 | 469 | 344 | 1,856 | 2,223 | 7,727 | |
| Last Close Price | 13.89 | 8.99 | 11.66 | 30.49 | 34.89 | 118.24 | |
| PS Ratio | 24.25 | 15.39 | 20.52 | 75.27 | 57.06 | 266.22 | |
| PB Ratio | 2.41 | 1.55 | 1.36 | 2.60 | 2.41 | 8.46 | |
| P/TBV Ratio | 2.44 | 1.55 | 1.36 | 2.60 | 2.41 | 8.46 | |
| EV/Sales Ratio | 16.68 | 6.94 | 5.95 | 51.17 | 42.65 | 233.76 | |
| Debt / Equity Ratio | 0.14 | 0.14 | 0.24 | 0.11 | 0.11 | 0.07 | |
| Net Debt / Equity Ratio | -0.76 | -0.76 | -0.75 | -0.85 | -0.92 | -0.97 | |
| Net Debt / EBITDA Ratio | 1.19 | 1.19 | 1.24 | 1.77 | 2.51 | 3.88 | |
| Net Debt / FCF Ratio | 1.29 | 1.29 | 1.84 | 2.20 | 3.26 | 4.26 | |
| Asset Turnover | 0.07 | 0.07 | 0.05 | 0.03 | 0.04 | 0.03 | |
| Quick Ratio | 4.42 | 4.42 | 5.50 | 8.23 | 9.45 | 5.97 | |
| Current Ratio | 5.08 | 5.08 | 5.77 | 8.66 | 9.62 | 6.11 | |
| Return on Equity (ROE) | -53.48% | -53.48% | -54.01% | -42.10% | -41.67% | -34.19% | |
| Return on Assets (ROA) | -27.11% | -27.11% | -26.80% | -22.83% | -20.35% | -16.99% | |
| Return on Capital Employed (ROCE) | -59.70% | -59.70% | -49.50% | -43.50% | -32.90% | -22.90% | |
| Earnings Yield | -25.15% | -39.63% | -43.70% | -17.62% | -15.95% | -3.04% | |
| FCF Yield | -24.13% | -38.02% | -29.87% | -14.95% | -11.66% | -2.70% | |
| Buyback Yield / Dilution | -9.64% | -9.64% | -11.35% | -15.33% | -8.57% | -26.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.